313 related articles for article (PubMed ID: 20625040)
1. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?
Goyal S; Chauhan SK; El Annan J; Nallasamy N; Zhang Q; Dana R
Arch Ophthalmol; 2010 Jul; 128(7):819-24. PubMed ID: 20625040
[TBL] [Abstract][Full Text] [Related]
2. Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease.
Goyal S; Chauhan SK; Dana R
Arch Ophthalmol; 2012 Jan; 130(1):84-9. PubMed ID: 21911653
[TBL] [Abstract][Full Text] [Related]
3. Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice.
Shi W; Ming C; Liu J; Wang T; Gao H
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):55-67. PubMed ID: 20640436
[TBL] [Abstract][Full Text] [Related]
4. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
5. b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern.
Hajrasouliha AR; Sadrai Z; Chauhan SK; Dana R
Cornea; 2012 Jul; 31(7):804-9. PubMed ID: 22467003
[TBL] [Abstract][Full Text] [Related]
6. Corneal lymphangiogenesis facilitates ocular surface inflammation and cell trafficking in dry eye disease.
Ji YW; Lee JL; Kang HG; Gu N; Byun H; Yeo A; Noh H; Kim S; Choi EY; Song JS; Lee HK
Ocul Surf; 2018 Jul; 16(3):306-313. PubMed ID: 29601983
[TBL] [Abstract][Full Text] [Related]
7. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation.
Cursiefen C; Maruyama K; Jackson DG; Streilein JW; Kruse FE
Cornea; 2006 May; 25(4):443-7. PubMed ID: 16670483
[TBL] [Abstract][Full Text] [Related]
8. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
9. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
[TBL] [Abstract][Full Text] [Related]
10. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
[TBL] [Abstract][Full Text] [Related]
11. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.
Bock F; Onderka J; Dietrich T; Bachmann B; Pytowski B; Cursiefen C
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):115-9. PubMed ID: 17909835
[TBL] [Abstract][Full Text] [Related]
12. Corneal lymphangiogenesis in dry eye disease is regulated by substance P/neurokinin-1 receptor system through controlling expression of vascular endothelial growth factor receptor 3.
Lee SJ; Im ST; Wu J; Cho CS; Jo DH; Chen Y; Dana R; Kim JH; Lee SM
Ocul Surf; 2021 Oct; 22():72-79. PubMed ID: 34311077
[TBL] [Abstract][Full Text] [Related]
13. Corneal lymphangiogenesis as a potential target in dry eye disease - a systematic review.
Chennakesavalu M; Somala SRR; Dommaraju SR; Peesapati MP; Guo K; Rosenblatt MI; Chang JH; Azar DT
Surv Ophthalmol; 2021; 66(6):960-976. PubMed ID: 33811911
[TBL] [Abstract][Full Text] [Related]
14. The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages.
Maruyama K; Nakazawa T; Cursiefen C; Maruyama Y; Van Rooijen N; D'Amore PA; Kinoshita S
Invest Ophthalmol Vis Sci; 2012 May; 53(6):3145-53. PubMed ID: 22511631
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye.
Lee HS; Chauhan SK; Okanobo A; Nallasamy N; Dana R
Cornea; 2011 Dec; 30(12):1465-72. PubMed ID: 21993466
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term corneal vascular effects of tafluprost eye drops.
Hos D; Koch KR; Bock F; Grajewski RS; Dietlein TS; Cursiefen C; Heindl LM
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1919-27. PubMed ID: 23624591
[TBL] [Abstract][Full Text] [Related]
17. Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis.
Nakao S; Zandi S; Hata Y; Kawahara S; Arita R; Schering A; Sun D; Melhorn MI; Ito Y; Lara-Castillo N; Ishibashi T; Hafezi-Moghadam A
Blood; 2011 Jan; 117(3):1081-90. PubMed ID: 20705758
[TBL] [Abstract][Full Text] [Related]
18. Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.
Singh N; Tiem M; Watkins R; Cho YK; Wang Y; Olsen T; Uehara H; Mamalis C; Luo L; Oakey Z; Ambati BK
Blood; 2013 May; 121(20):4242-9. PubMed ID: 23476047
[TBL] [Abstract][Full Text] [Related]
19. Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease.
Lee HS; Hos D; Blanco T; Bock F; Reyes NJ; Mathew R; Cursiefen C; Dana R; Saban DR
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3140-8. PubMed ID: 26024097
[TBL] [Abstract][Full Text] [Related]
20. Dry eye predisposes to corneal neovascularization and lymphangiogenesis after corneal injury in a murine model.
Cho YK; Archer B; Ambati BK
Cornea; 2014 Jun; 33(6):621-7. PubMed ID: 24727637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
